| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Awny Samaan Botros Farajallah is Chief Medical Officer at TKPHF. Awny Samaan Botros Farajallah's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.9M at current prices.
The TKPHF filings lean toward selling, a net 14,006 shares.
Awny Samaan Botros Farajallah has 2 Form 4 filings on record from July 2026 to August 2026, all as Chief Medical Officer at Takeda Pharmaceutical (TKPHF), 2026.
The 2 reported transactions were 1 open-market sale and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $240K.
The only open-market sale was 14,006 shares of TKPHF at an average $17.10 on August 10, 2026, about $240K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | Chief Medical Officer | Sell | 14,006 | $17.10 | $239,502.60 | -10.8% |